The costs of running this huge site are paid for by ads. Please consider registering and becoming a Supporting Member for an ad-free experience. Thanks, ECF team.

FDA public hearing (live) on further promoting/subsidizing more NRT

Discussion in 'FDA Regulations' started by Bill Godshall, Jan 26, 2018.

Thread Status:
Not open for further replies.
Image has been removed.
URL has been removed.
Email address has been removed.
Media has been removed.
  1. Bill Godshall

    Bill Godshall Executive Director
    Smokefree Pennsylvania
    ECF Veteran

    Supporting member
    Apr 2, 2009
    FDA holds 1/26/2017 public hearing (that can be watched live) to further promote/protect/subsidize more Big Pharma NRT drugs (since the NRT products approved by FDA during the past 25 years have had a 95% failure rate)
    Public Meeting on FDA Approach to Evaluating Nicotine Replacement Therapies

    So after Mitch Zeller banned sales of new vapor products, banned truthful claims about them, and banned all vapor sales several years from now (via the Deeming Rule), he's giving a huge gift to his old employer GSK and its NRT cartel partner J&J to give them financial incentives to urge them to develop new NRT products.

    Near the bottom of FDA's webpage is a link to watch the public hearing.

    FDA's notice of the public hearing, and docket to submit comments are below
    Advancing Medicinal Nicotine Replacement Therapies as New Drugs – A new step in FDA’s comprehensive approach to tobacco and nicotine | FDA Voice

    https://www.federalregister.gov/documents/2017/11/30/2017-25671/approach-to-evaluating-nicotine-replacement-therapies-public-hearing-request-for-comments

    They are currently taking a lunch break.
     
    • Informative Informative x 5
    • Like Like x 1
Thread Status:
Not open for further replies.

Share This Page

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice